Silo Pharma Files S-1 Registration Statement
Ticker: SILO · Form: S-1 · Filed: Apr 25, 2025 · CIK: 1514183
| Field | Detail |
|---|---|
| Company | Silo Pharma, Inc. (SILO) |
| Form Type | S-1 |
| Filed Date | Apr 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: s-1, registration-statement, pharmaceuticals
TL;DR
Silo Pharma just filed an S-1, looks like they're gearing up to sell stock.
AI Summary
Silo Pharma, Inc. filed an S-1 registration statement on April 25, 2025, to register securities under the Securities Act of 1933. The company, formerly known as Uppercut Brands, Inc., is incorporated in Nevada and operates in the Pharmaceutical Preparations sector. Its principal executive offices are located at 677 N. Washington Blvd, Sarasota, Florida.
Why It Matters
This S-1 filing indicates Silo Pharma is preparing to offer securities to the public, which could lead to new funding and increased trading activity.
Risk Assessment
Risk Level: medium — S-1 filings are often associated with new public offerings, which carry inherent market and execution risks for investors.
Key Numbers
- 333-286777 — SEC File Number (Identifies this specific registration filing)
- 0001514183 — Central Index Key (Unique identifier for Silo Pharma, Inc. in SEC filings)
Key Players & Entities
- Silo Pharma, Inc. (company) — Registrant
- April 25, 2025 (date) — Filing Date
- Securities Act of 1933 (legal_document) — Governing Act
- Uppercut Brands, Inc. (company) — Former Company Name
- Nevada (jurisdiction) — State of Incorporation
- 677 N. Washington Blvd, Sarasota, Florida (address) — Principal Executive Offices
- Eric Weisblum (person) — Chief Executive Officer
FAQ
What is the purpose of this S-1 filing?
The S-1 filing is a registration statement required by the Securities Act of 1933 for companies planning to offer securities to the public.
When was this S-1 filing submitted to the SEC?
The S-1 filing was submitted to the SEC on April 25, 2025.
What is Silo Pharma, Inc.'s primary business sector?
Silo Pharma, Inc. operates in the Pharmaceutical Preparations sector, with a Standard Industrial Classification code of 2834.
Has Silo Pharma, Inc. operated under different names previously?
Yes, Silo Pharma, Inc. was formerly known as Uppercut Brands, Inc., Point Capital, Inc., and Gold Swap Inc.
Where are Silo Pharma, Inc.'s principal executive offices located?
The company's principal executive offices are located at 677 N. Washington Boulevard, Sarasota, Florida, 34236.
Filing Details
This Form S-1 (Form S-1) was filed with the SEC on April 25, 2025 by Eric Weisblum regarding Silo Pharma, Inc. (SILO).